Protein kinases in mammary gland development and cancer

被引:17
作者
Kumar, R [1 ]
Wang, RA [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
关键词
receptor tyrosine kinases; HER2; heregulin; development; cancer;
D O I
10.1002/jemt.10176
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Protein kinases, the enzymes responsible for phosphorylation of a wide variety of proteins, are the largest class of genes known to regulate growth, development, and neoplastic transformation of mammary gland. Mammary gland growth and maturation consist of a series of highly ordered events involving interactions among several distinct cell types that are regulated by complex interactions among many steroid hormones and growth factors. The mammary gland is one of the few organ systems in mammals that complete their morphologic development postnatally during two discrete physiologic states, puberty and pregnancy. Thus, the mammary gland is an excellent model for studying normal development and the early steps of tumor formation. The susceptibility of the mammary gland to tumorigenesis is influenced by its normal development, particularly during stages of puberty and pregnancy. Numerous experimental and epidemiological studies have suggested that specific details in the development of the mammary gland play a critical role in breast cancer risk. Mammary gland development is characterized by dynamic changes in the expression and functions of protein kinases. Perturbations in the regulated expression or function of protein kinases or their associated signaling pathways can lead to malignant transformation of the breast. For example, overexpression of several receptor-tyrosine kinases, including human epidermal growth factor receptor and HER2/Neu, has been shown to contribute to the development of breast cancer. Since receptor-tyrosine kinases regulate several essential processes such as mitogenesis, motility, invasion, cell survival, and angiogenesis, targeting receptor-tyrosine kinases may have important implications in designing strategies against breast cancer.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 91 条
[1]   Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1 [J].
Adam, L ;
Vadlamudi, R ;
Mandal, M ;
Chernoff, J ;
Kumar, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :12041-12050
[2]   Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase [J].
Adam, L ;
Vadlamudi, R ;
Kondapaka, SB ;
Chernoff, J ;
Mendelsohn, J ;
Kumar, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :28238-28246
[3]  
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[4]   The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions [J].
Alroy, I ;
Yarden, Y .
FEBS LETTERS, 1997, 410 (01) :83-86
[5]   Changes in the normal human breast throughout the menstrual cycle: Relevance to breast carcinogenesis [J].
Anderson, E ;
Clarke, RB ;
Howell, A .
ENDOCRINE-RELATED CANCER, 1997, 4 (01) :23-33
[6]  
Baeckström D, 2000, INT J ONCOL, V16, P1081
[7]   Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells [J].
Bagheri-Yarmand, R ;
Mandal, M ;
Taludker, AH ;
Wang, RA ;
Vadlamudi, RK ;
Kung, HJ ;
Kumar, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :29403-29409
[8]   Interactions between progestins and heregulin (HRG) signaling pathways:: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas [J].
Balañá, ME ;
Lupu, R ;
Labriola, L ;
Charreau, EH ;
Elizalde, PV .
ONCOGENE, 1999, 18 (46) :6370-6379
[9]   Cyclin D1 in breast cancer [J].
Barnes, DM ;
Gillett, CE .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :1-15
[10]  
Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO